"NASA has been an instrumental partner and customer as we've scaled our pharmaceutical drug manufacturing program significantly over the last year," said John Vellinger, Redwire's President of In-Space Industries. "Additional PIL-BOX investigations from NASA and commercial partners will enable Redwire to optimize the infrastructure to launch, test, manufacture, and return high-value space enabled pharmaceutical products and establish a new market in LEO"
The PIL-BOX platform, which has already completed 28 missions, offers pharmaceutical developers access to microgravity to cultivate small-batch crystals of protein-based drugs and other biologically relevant compounds. This low Earth orbit environment provides unique conditions for growing more uniform and less defective crystals, a factor that can accelerate drug development and improve formulation quality.
Previous experiments using PIL-BOX have contributed valuable data in the quest to enhance therapies for conditions such as cardiovascular disease, obesity, and diabetes, showcasing the broader potential of space-enabled research.
Related Links
Redwire
Mars News and Information at MarsDaily.com
Lunar Dreams and more
Subscribe Free To Our Daily Newsletters |
Subscribe Free To Our Daily Newsletters |